Despite clear evidence that hormonal fluctuations during menstruation impact blood glucose, these effects are often overlooked in diabetes care.
Our research reveals low awareness of DKA and ketone testing among type 2 diabetes patients on SGLT2 inhibitors, highlighting urgent education needs.
dQ&A research reveals primary care challenges in adopting diabetes tech, highlighting needs for CGM training, simpler tools, and better industry support.
